Share this post on:

Product Name :
Bitopertin

Search keywords :
Bitopertin

drugId :
null

Target Vo:
Glycine transporter 1

Target Vo Short Name :
GlyT1

Moa_Name:
Glycine transporter 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :
Disc Medicine Inc

Active Indication_Name:
Protoporphyria, Erythropoietic

In Active Indication_Name:
beta-Thalassemia

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-STAT3 (Tyr705) Antibody (YA146)
Collagen I Antibody
ABCG2 Antibody: ABCG2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to ABCG2. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related